Gene Symbol |
Sexually Dimorphic Changes (Fold Chang) |
P-value |
Top 5 of Related Drugs |
Major Biological Functions/Pathways |
SLC3A1 |
2.35 |
7.27 × 10-12 |
N/A |
Carbohydrate/cellular amino acid metabolism, ion/amino acid/basic amino acid/Lysine/transmembrane transport |
CYP7A1 |
2.1 |
1.28 × 10-10 |
N/A |
Bile acid biosynthetic process, cholesterol catabolic process, xenobiotic/steroid/bile acid/cellular lipid metabolism, cholesterol homeostasis, oxidation-reduction process, regulation of bile acid biosynthetic process, cellular response to glucose stimulus/cholesterol |
ACSL4 |
2 |
2.66 × 10-3 |
N/A |
Lipid/fatty acid/triglyceride/cellular lipid metabolism, response to nutrient, learning or memory, fatty acid transport, dendrite development, triglyceride biosynthetic process, long-chain fatty-acyl-CoA biosynthetic process, embryonic process involved in female pregnancy/response to interleukin-15 |
CYP3A7 |
1.83 |
9.35 × 10-8 |
Cisapride, Idazolam, Vitamin D, Xenobiotics |
Xenobiotic metabolic process, oxidation-reduction process |
GSTA1 |
1.82 |
1.32× 10-4 |
Busulfan, Chlorambucil, Cyclophosphamide, Doxorubicin, Etoposide |
Glutathione/xenobiotic metabolism |
CYP3A4 |
1.73 |
5.25 × 10-6 |
Alprazolam, Anthracycline, Asparaginase, Cisapride,Citalopram |
Lipid/xenobiotic/steroid/androgen/monoterpenoid/drug/vitamin D/heterocycle metabolic process, steroid/alkaloid/exogenous drug catabolism, oxidation-reduction process, oxidative demethylation |
GSTA2 |
1.69 |
2.66 × 10-3 |
N/A |
Glutathione/xenobiotic metabolism |
UGT2B17 |
1.59 |
2.00 × 10-4 |
Losartan |
Metabolic/steroid metabolic process/retinoic acidbinding/glucuronosyltransferase activity/transferase activity/ transferring hexosyl groups |
SLC13A1 |
1.57 |
1.66 × 10-2 |
Succinic acid |
Transporter activity/symporter activity/sodium:sulfate symporter activity/ion transport/dium ion transport/sulfate transport/transmembrane transport |
ADH1A |
1.53 |
3.00 × 10-5 |
N/A |
Alcohol/xenobiotic metabolism, ethanol oxidation, oxidation-reduction process |